Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
No edit summary
Line 2,213: Line 2,213:
|
|
| ||
| ||
|
|
|}<br />
==WHO Classification of Tumours of the Central Nervous System Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Medulloblastoma, WNT-activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Paediatric-Type Diffuse High-Grade Gliomas
|Overview
|
|
|
|
|
|
|
|2021 template added
|-
|Diffuse Midline Glioma, H3 K27-Altered
|Disease
|Laveniya Satgunaseelan (Linda Cooley - previous version)
|
|
|PENDING
|
|Laveniya Satgunaseelan (LS)
|
|2021 template added
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant
|Disease
|Xiaolin (Lynn) Hu
|2/21/2022
|
|PENDING
|
|LS
|
|2021 template added
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype
|Disease
|Madina Sukhanova
|10/28/2022
|
|PENDING
|
|LS
|
|2021 template added
|-
|Infant-Type Hemispheric Glioma
|Disease
|
|
|
|
|
|
|
|2021 template added
|-
|Astrocytoma, IDH-Mutant
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|PENDING
|
|LS
|
|2021 template added
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|PENDING
|
|LS
|
|2021 template added
|-
|Ganglioglioma
|Disease
|Leila Moayed-Aloei
|6/30/2022
|
|COMPLETE
|
|LS
|
|2021 template added
|-
|Pilocytic Astrocytoma
|Disease
|Jeremy Pulvers
|9/13/2022
|
|PENDING
|
|LS
|
|2021 template added
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|
|
|
Line 2,533: Line 2,236:
|
|
|
|
|-
|}<br />
==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Adenoid Cystic Carcinoma
|Disease||Katherine Geiersbach
|10/12/02022
|
|PENDING
|
|Hui Chen
|
|2021 template added
|-
|Secretory Carcinoma
|Disease
|Hui Chen
|10/12/2022
|
|PENDING
|
|Katherine Geiersbach
|
|2021 template added
|-
|-
|}<br />
|}<br />
Line 3,672: Line 3,341:
|
|
|-
|-
|}
|}<br />
==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Adenoid Cystic Carcinoma
|Disease||Katherine Geiersbach
|10/12/02022
|
|PENDING
|
|Hui Chen
|
|2021 template added
|-
|Secretory Carcinoma
|Disease
|Hui Chen
|10/12/2022
|
|PENDING
|
|Katherine Geiersbach
|
|2021 template added
|-
|}<br />


==WHO Breast tumours  (5th ed.) Content==
==WHO Breast tumours  (5th ed.) Content==